Drupal.behaviors.print = function(context) {window.print();window.close();}>
Chemoprevention Study Identifies miRNA-34c as Potential Surrogate Endpoint for Future Trials
January 17, 2013
Chemoprevention Study Identifies miRNA-34c as Potential Surrogate Endpoint for Future Trials
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Rosetta Publishes Data on microRNA-Based Lung Cancer Assay
July 5, 2012 / Gene Silencing News
Rosetta Genomics Launches Lung Cancer Diagnostic
July 14, 2011 / Gene Silencing News
TGen Researchers Link miRNA-328 with Brain Metastasis
April 7, 2011 / Gene Silencing News
Tools & Techniques: TALENs for miRNA Manipulation; CLASH for miRNA-Target Analysis; and More
May 21, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Novartis, Tekmira, and More
May 21, 2013 / Gene Silencing News